Cited by 147Barrier Structure and Function StudiesBrain Metastases and TreatmentProtease and Inhibitor Mechanisms

Transmigration of melanoma cells through the blood-brain barrier: role of endothelial tight junctions and melanoma-released serine proteases.

Open access
Fazakas, Csilla, Wilhelm, Imola, Nagyőszi, Péter, Farkas, Attila E., Haskó, János, Molnár, Judit, Bauer, Hannelore, Bauer, Hans-Christian +4 more·2011·PLoS ONE

Abstract

Malignant melanoma represents the third common cause of brain metastasis, having the highest propensity to metastasize to the brain of all primary neoplasms in adults. Since the central nervous system lacks a lymphatic system, the only possibility for melanoma cells to reach the brain is via the blood stream and the blood-brain barrier. Despite the great clinical importance, mechanisms of transmigration of melanoma cells through the blood-brain barrier are incompletely understood. In order to investigate this question we have used an in vitro experimental setup based on the culture of cerebral endothelial cells (CECs) and the A2058 and B16/F10 melanoma cell lines, respectively. Melanoma cells were able to adhere to confluent brain endothelial cells, a process followed by elimination of protrusions and transmigration from the luminal to the basolateral side of the endothelial monolayers. The transmigration process of certain cells was accelerated when they were able to use the routes preformed by previously transmigrated melanoma cells. After migrating through the endothelial monolayer several melanoma cells continued their movement beneath the endothelial cell layer. Melanoma cells coming in contact with brain endothelial cells disrupted the tight and adherens junctions of CECs and used (at least partially) the paracellular transmigration pathway. During this process melanoma cells produced and released large amounts of proteolytic enzymes, mainly gelatinolytic serine proteases, including seprase. The serine protease inhibitor Pefabloc® was able to decrease to 44-55% the number of melanoma cells migrating through CECs. Our results suggest that release of serine proteases by melanoma cells and disintegration of the interendothelial junctional complex are main steps in the formation of brain metastases in malignant melanoma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0020758

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proteolytic enzymes such as heparanase and seprase are important for the capacity of metastatic cells to traverse the BBB and occupy the brain, and micrometastases give rise to macrometastases through proliferation along brain microvessels.

    “proteolytic enzymes such as heparanase and seprase are important for the capacity of metastatic cells to traverse the BBB and occupy the brain”

    From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Fazakas et al., 2011

  • To cross the BBB, tumor cells bind endothelial cells and disrupt their tight junctions, and melanoma cells adhere to and disturb the interaction of brain endothelial cells through a disruption of tight and adherence junction proteins such as Claudin 5 and ZO-1.

    “To cross the BBB, tumor cells bind endothelial cells and disrupt their tight junctions”

    From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Fazakas et al., 2011

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fazakas, C., Wilhelm, I., Nagyőszi, P., Farkas, A. E., Haskó, J., Molnár, J., Bauer, H., Bauer, H.-C., Ayaydin, F., Dung, N. T. K., Siklós, L., & Krizbai, I. A.
Affiliations
  • HUN-REN Szegedi Biológiai Kutatóközpont (HU)
  • University of Salzburg (AT)
Corresponding author
Krizbai, István A.
Venue
PLoS ONE
Published
2011-06-02
Volume
6
Issue
6
Pages
e20758
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1985649889
Cited by
147
References
43
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 12 · 2022: 5 · 2021: 12 · 2020: 11 · 2019: 17 · 2018: 12 · 2017: 5 · 2016: 13 · 2015: 13 · 2014: 13 · 2013: 16 · 2012: 2
FWCI
5.84
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Brain Metastases and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
melanoma, brain metastases, blood-brain barrier, endothelial transmigration, tight junctions, serine protease, seprase, paracellular pathway, adherens junctions, brain endothelial cells, protease inhibitors, tumor cell adhesion
MeSH terms
Animals, Blood-Brain Barrier, Humans, Melanoma, Tight Junctions, Endothelial Cells, Cell Line, Tumor, Mice, Rats, Serine Proteases, Transendothelial and Transepithelial Migration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review